IMAX Corporation

Informe acción NYSE:IMAX

Capitalización de mercado: US$1.9b

IMAX Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de IMAX de 34.1% y 7.6% por año respectivamente. Se prevé que el BPA crezca en un 27.5% al año. Se espera que la rentabilidad financiera sea de 16.4% en 3 años.

Información clave

34.1%

Tasa de crecimiento de los beneficios

27.54%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Entertainment17.5%
Tasa de crecimiento de los ingresos7.6%
Rentabilidad financiera futura16.39%
Cobertura de analistas

Good

Última actualización04 May 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.

IMAX Corporation: Strong Network Effect And Visible Growth Ahead

Jan 09

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

Sep 09
Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

Aug 04
Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Jun 13
An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

May 17
Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

May 02
IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

Apr 19
Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

Apr 04
Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Mar 15
We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Mar 09

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

Jan 08
Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation: Overseas Growth Opportunities

Dec 24

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

Dec 10
IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 23
IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Nov 07
After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Oct 31
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Oct 13
If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

Oct 10

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Sep 30
When Should You Buy IMAX Corporation (NYSE:IMAX)?
User avatar

Calculated Global Expansion And Innovative Content Slate Set To Propel Growth

IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Aug 23
Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Jul 30

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

Jul 26
Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

Is IMAX (NYSE:IMAX) A Risky Investment?

Jun 19
Is IMAX (NYSE:IMAX) A Risky Investment?

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

May 22
Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation: Good Reasons To Be Bullish

Apr 08

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 01
IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Previsiones de crecimiento de beneficios e ingresos

NYSE:IMAX - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/2028501891371827
12/31/20274729912916610
12/31/2026442749714511
3/31/20264053790124N/A
12/31/20254103585127N/A
9/30/20253784064109N/A
6/30/2025362332977N/A
3/31/2025360254089N/A
12/31/2024352263071N/A
9/30/2024346231963N/A
6/30/2024358211757N/A
3/31/202436726-926N/A
12/31/2023375252659N/A
9/30/2023387254371N/A
6/30/202335242148N/A
3/31/2023328-71142N/A
12/31/2022301-23-1517N/A
9/30/2022311-15-426N/A
6/30/2022299-15-718N/A
3/31/2022276-21-713N/A
12/31/2021255-22-126N/A
9/30/2021202-54-25-12N/A
6/30/2021183-93-29-19N/A
3/31/2021141-109-50-40N/A
12/31/2020137-144-32-23N/A
9/30/2020205-104-28-8N/A
6/30/2020254-48-821N/A
3/31/2020350-115697N/A
12/31/201939647N/A90N/A
9/30/201938030N/A109N/A
6/30/201937626N/A112N/A
3/31/201937023N/A94N/A
12/31/201837423N/A110N/A
9/30/201839126N/A90N/A
6/30/201840820N/A95N/A
3/31/201839711N/A101N/A
12/31/20173812N/A85N/A
9/30/20173626N/A96N/A
6/30/201734910N/A79N/A
3/31/201735318N/A72N/A
12/31/201637629N/A78N/A
9/30/201638942N/A87N/A
6/30/201638848N/A102N/A
3/31/201640466N/A83N/A
12/31/201537455N/A84N/A
9/30/201535753N/A57N/A
6/30/201533250N/A70N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (34.1% al año) de IMAX es superior a la tasa de ahorro (3.5%).

Beneficios vs. Mercado: Se prevé que los beneficios (34.1% al año) de IMAX crezcan más rápidamente que el mercado US (16% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de IMAX crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (7.6% al año) de IMAX crezcan más despacio que el mercado de US (11.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.6% al año) de IMAX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de IMAX sea baja dentro de 3 años (16.4%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/05 02:59
Precio de las acciones al final del día2026/05/05 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

IMAX Corporation está cubierta por 20 analistas. 11 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.